Lilly to Participate in Bernstein Operational Decisions Conference
INDIANAPOLIS, Nov. 12, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020. Andrew Adams, Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly's anti-COVID-19 platform, Jeff Emmick, M.D., Ph.D., vice president of diabetes product development, and Mark Mintun, M.D., vice president of pain and neurodegeneration research and president of Avid Radiopharmaceuticals, will participate in a virtual fireside chat at 11:00 a.m., Eastern Time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Eli Lilly and Company
View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-to-participate-in-bernstein-operational-decisions-conference-301172168.html
SOURCE Eli Lilly and Company
Company Codes: NYSE:LLY